CID 169502113

Mirabegron metabolite m17

Structural Information

Molecular Formula
C22H28N2O8
SMILES
C1=CC=C(C=C1)C(CNCCC2=CC(=C(C=C2)N)OC3C(C(C(C(O3)C(=O)O)O)O)O)O
InChI
InChI=1S/C22H28N2O8/c23-14-7-6-12(8-9-24-11-15(25)13-4-2-1-3-5-13)10-16(14)31-22-19(28)17(26)18(27)20(32-22)21(29)30/h1-7,10,15,17-20,22,24-28H,8-9,11,23H2,(H,29,30)
InChIKey
RTUDXGJPMYKMKG-UHFFFAOYSA-N
Compound name
6-[2-amino-5-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

0
Patents

448.18457 Da
Monoisotopic Mass

-2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 449.191846 204.4
[M+Na]+ 471.173788 205.3
[M-H]- 447.177294 207.1
[M+NH4]+ 466.218393 206.9
[M+K]+ 487.147728 203.7
[M+H-H2O]+ 431.181830 194.7
[M+HCOO]- 493.182771 215.3
[M+CH3COO]- 507.198421 230.0
[M+Na-2H]- 469.159236 200.7
[M]+ 448.18402142 200.7
[M]- 448.18511858 200.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.